Riskpilot← Back to searchSign inGet full accessAPOTEKET I SON AS
ASActiveOrg 991728147Kolåsveien 4, 1555 SonRetail sale of pharmaceutical products · NACE 4773Est. 200725 employees
Revenue 2024
NOK 43,6M
+11% vs 2023
EBITDA margin
3.6%
+8% vs 2023
Equity ratio
1.4%
Financial strength
Net profit 2024
NOK 1,2M
+10% vs 2023
| Revenue | NOK 43,6M | +11% |
| EBITDA | NOK 1,6M | +8% |
| Net profit | NOK 1,2M | +10% |
| Total assets | NOK 7,8M | -30% |
| Equity | NOK 110K | -88% |
| Employees | 25 | — |
Legal name
APOTEKET I SON AS
Org number
991728147
Legal form
Aksjeselskap
NACE code
4773 · Retail sale of pharmaceutical products
Founded
19. september 2007
Share capital
NOK 100 000
Employees
25 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Daglig leder og styrets leder i fellesskap.
Company purpose
Salg av legemidler og helserelaterte produkter samt naturlig tilhørende handelsvarer, fortrinnsvis ved apotekdrift, samt hva hermed står i forbindelse herunder å delta i andre selskaper.
Address
Kolåsveien 4, 1555 Son
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 30 492 | 32 600 | 33 473 | 39 140 | 43 580 |
| Staff expenses | −4 421 | −4 693 | −5 213 | −6 730 | −6 918 |
| EBITDA | 2 563 | 2 324 | 1 822 | 1 457 | 1 567 |
| Depreciation & amort. | −78 | −68 | −90 | −81 | −61 |
| EBIT | 2 485 | 2 257 | 1 732 | 1 376 | 1 507 |
| Net financials | 0 | −2 | −1 | −1 | 4 |
| Profit before tax | 2 486 | 2 254 | 1 731 | 1 375 | 1 511 |
| Tax | 547 | 497 | 382 | 303 | 332 |
| Net profit | 1 939 | 1 757 | 1 350 | 1 072 | 1 179 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 6 346 | 6 782 | 6 179 | 11 007 | 7 751 |
| Equity | 101 | 109 | 859 | 931 | 110 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 6 244 | 6 673 | 5 320 | 10 076 | 7 641 |
| Total debt | 6 244 | 6 673 | 5 320 | 10 076 | 7 641 |
EBITDA margin
3.6%
This company
15.8%
Market median
-77% vs market
20202024
Equity ratio
1.4%
This company
38.2%
Market median
-96% vs market
20202024
Return on equity
1076.0%
This company
18.4%
Market median
+5748% vs market
20202024
Net profit margin
2.7%
This company
8.1%
Market median
-67% vs market
20202024
Asset turnover
5.62×
This company
1.12×
Market median
+402% vs market
20202024
Debt / equity
69.77×
This company
0.62×
Market median
-11153% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
IV Chief Executive Officer | Chief Executive Officer | 2022 |
| Former (1) | ||
MK Deputy Member | Deputy Member | 2007 – 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Chairman | 2022 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 50% | 50% | 2022 | |
| Company | 50% | 50% | 2022 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Valle Tangen As
APOTEKET I SON AS Board members of APOTEKET I SON AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Inge Valle Tangen | Chief Executive Officer | 0 companies |
| Merete Kildahl | Deputy Member | 0 companies |
| Are Egeland | Chairman | 0 companies |